Previous Stories (Continued ...) Ranbaxy and Daiichi Sankyo launch hybrid business in Brazil (Corporate News 17-Apr 12:20) Ranbaxy Laboratories allots equity shares (Corporate News 15-Apr 13:40) Ranbaxy Laboratories to announce Q1 results (Corporate News 09-Apr 16:47) Ranbaxy resumes the supply of Atorvastatin tablets to US market (Corporate News 01-Apr 10:32) Ranbaxy Lab drops on profit booking (Hot Pursuit 18-Mar 14:17) Ranbaxy's arm enters into an in-licensing business agreement with Alembic (Corporate News 05-Mar 15:12) Ranbaxy Lab hits 52-week low after weak Q4 numbers (Hot Pursuit 28-Feb 10:59) Ranbaxy Laboratories (Results - Analysis 27-Feb 14:29) Ranbaxy Lab off 8.1% in 2 days after poor Q4 results (Hot Pursuit 27-Feb 12:02) Ranbaxy laboratories (Analyst Meet / AGM - Conference Call 27-Feb 10:51) Ranbaxy Laboratories reports net loss of Rs 616.10 crore in the December 2012 quarter (Results - Announcements 26-Feb 17:25) Ranbaxy slides on profit booking (Hot Pursuit 26-Feb 16:31) Ranbaxy Labs tumbles after weak Q4 outcome (Hot Pursuit 26-Feb 15:33) Ranbaxy gains after resuming production of Atorvastatin for US market (Hot Pursuit 25-Feb 10:28) Ranbaxy Laboratories to announce audited financial results (Corporate News 29-Jan 16:54) Ranbaxy and Daiichi Sankyo to leverage synergies in Thailand (Corporate News 16-Jan 10:02) Ranbaxy Lab in the pink of health (Hot Pursuit 16-Jan 09:43) Ranbaxy Laboratories allots equity shares (Corporate News 11-Jan 16:43) Ranbaxy Laboratories allots equity shares (Corporate News 21-Dec 12:09) Ranbaxy Lab extends gains (Hot Pursuit 29-Nov 11:36) Ranbaxy Lab gains on launch of Absorica Capsules in the US (Hot Pursuit 26-Nov 13:42) Ranbaxy launches Absorica (Isotretinoin) Capsules in US Healthcare Market (Corporate News 26-Nov 12:52) Ranbaxy Laboratories issues redeemable non-convertible debentures (Corporate News 23-Nov 17:35) Ranbaxy Lab drops on recall of Atorvastatin from US market (Hot Pursuit 23-Nov 12:23) Ranbaxy Laboratories recalls Atorvastatin from USA market (Corporate News 23-Nov 12:04) Ranbaxy Laboratories (Results - Analysis 12-Nov 19:32) Ranbaxy Laboratories (Analyst Meet / AGM - Conference Call 09-Nov 10:31) Ranbaxy Laboratories reports net profit of Rs 552.19 crore in the September 2012 quarter (Results - Announcements 08-Nov 17:51) Ranbaxy Lab drops after Q3 earnings (Hot Pursuit 08-Nov 15:23) Ranbaxy Laboratories allots equity shares (Corporate News 11-Oct 14:25) Ranbaxy Lab extends gains after launching a generic drug in US (Hot Pursuit 10-Oct 10:25) Ranbaxy Lab gains after launching a generic drug in US (Hot Pursuit 09-Oct 12:19) Ranbaxy launches Authorized Generic of Evoxac in the US Healthcare market (Corporate News 09-Oct 10:48) Ranbaxy Laboratories to announce Q3 results (Corporate News 27-Sep 17:25) Ranbaxy Lab in the pink of health (Hot Pursuit 14-Sep 10:25) Ranbaxy gets approval to set up greenfield manufacturing facility in Malaysia (Corporate News 13-Sep 16:15) Ranbaxy Lab drops after 4-day 7.9% rally (Hot Pursuit 28-Aug 15:16) Ranbaxy Lab hits 52-week high (Hot Pursuit 27-Aug 13:41) Ranbaxy Lab drops after 2-day 6.5% rally (Hot Pursuit 24-Aug 10:28) Ranbaxy Lab hits 52-week high (Hot Pursuit 23-Aug 10:26) Ranbaxy Lab in the pink of health (Hot Pursuit 22-Aug 12:50) Ranbaxy launches authorized generic of Pioglitazone in US (Corporate News 17-Aug 16:31) Ranbaxy Laboratories (Analyst Meet / AGM - Conference Call 11-Aug 13:57) Ranbaxy Laboratories (Results - Analysis 11-Aug 13:55) Ranbaxy Laboratories reports net loss of Rs 925.67 crore in the June 2012 quarter (Results - Announcements 09-Aug 19:14) Ranbaxy drops after reporting net loss in Q2 June 2012 (Hot Pursuit 09-Aug 16:33) Ranbaxy gains after in-licensing agreement with Gilead Sciences (Hot Pursuit 03-Aug 13:38) Ranbaxy enter into an in-licensing agreement with Gilead Sciences to reduce manufacturing cost and improve availability of emtricitabine (Corporate News 03-Aug 12:32) Ranbaxy Laboratories allots equity shares (Corporate News 11-Jul 15:32) Ranbaxy Laboratories to announce Q2 results (Corporate News 06-Jul 11:09) Ranbaxy gains after tie up with Daiichi to sell drugs in Venezuela (Hot Pursuit 21-Jun 15:12) Daiichi Sankyo and Ranbaxy launch hybrid business in Venezuela (Corporate News 20-Jun 11:00) Ranbaxy announces USFDA approval of Cip-Isotretinoin NDA (Corporate News 28-May 15:03) Ranbaxy Laboratories (Results - Analysis 10-May 16:37) Ranbaxy Laboratories (Analyst Meet / AGM - Conference Call 10-May 16:32) Ranbaxy Laboratories reports net profit of Rs 827.23 crore in the March 2012 quarter (Results - Announcements 09-May 14:45) Ranbaxy Laboratories appoints additional director (Corporate News 09-May 14:42) Ranbaxy Lab in the pink of health after stellar Q1 outcome (Hot Pursuit 09-May 14:39) Ranbaxy launches Synriam (Corporate News 25-Apr 16:04) Ranbaxy Labs extends gains as unit to launch Sevikar in Romania (Hot Pursuit 20-Apr 09:55) Daiichi Sankyo and Ranbaxy to expand hybrid business model in Romania (Corporate News 19-Apr 14:06) Ranbaxy Labs gains as unit to launch Sevikar in Romania (Hot Pursuit 19-Apr 13:29) Ranbaxy Laboratories allots equity shares (Corporate News 18-Apr 10:28) Ranbaxy Laboratories to announce financial results (Corporate News 11-Apr 12:49) Ranbaxy's Mohali SEZ facility begins export of Atorvastatin to the US market (Corporate News 02-Apr 12:35) Ranbaxy Lab drops on profit taking after 4-day 14.2% rally (Hot Pursuit 02-Apr 10:37) Ranbaxy receives approval to Market RAN - ROSUVASTATIN in Canada (Corporate News 31-Mar 14:14) Ranbaxy opens new manufacturing facility in Morocco (Corporate News 12-Mar 12:10) Ranbaxy launches Atorvastatin in Germany (Corporate News 06-Mar 12:19) Ranbaxy becomes the first company to launch generic Atorvastatin in Italy, Netherlands & Sweden (Corporate News 06-Mar 11:52) Ranbaxy Lab in the pink of health on launch of generic Atorvastatin (Hot Pursuit 06-Mar 11:31) Ranbaxy Laboratories (Results - Analysis 24-Feb 15:49) Ranbaxy Laboratories (Analyst Meet / AGM - Conference Call 24-Feb 15:46) Ranbaxy Laboratories reports net loss of Rs 2710.32 crore in the December 2011 quarter (Results - Announcements 23-Feb 15:33) Ranbaxy trades flat after Q4 earnings (Hot Pursuit 23-Feb 15:27) Ranbaxy launches Atorvastatin in Australia (Corporate News 21-Feb 11:45) Ranbaxy Laboratories to announce financial results (Corporate News 31-Jan 10:55) Ranbaxy tumbles after filing consent decree in US court‎ (Hot Pursuit 27-Jan 09:43) Ranbaxy Laboratories allots equity shares (Corporate News 13-Jan 15:41) Ranbaxy to market Daiichi Sankyo's innovative products in Malaysia (Corporate News 21-Dec 14:14) Ranbaxy announces consent decree with U.S. Food and Drug Administration (Corporate News 21-Dec 12:30) Ranbaxy inches up after settlement with US FDA (Hot Pursuit 21-Dec 09:29) Ranbaxy launches authorized generic version of caduet in the US (Corporate News 07-Dec 11:24) Ranbaxy Labs in pink of health on launch of generic drug in US (Hot Pursuit 07-Dec 09:17) Ranbaxy announces launch of Atorvastatin (Corporate News 01-Dec 10:15) Ranbaxy Labs spurts on USFDA approval for generic Lipitor (Hot Pursuit 01-Dec 09:35) Ranbaxy Labs may gallop on getting USFDA approval for generic Lipitor (Market Commentary - Stock Alert 01-Dec 08:57) Ranbaxy Labs slips as Lipitor patent expires today (Hot Pursuit 30-Nov 10:49) Ranbaxy jumps on likely approval for Lipitor (Hot Pursuit 25-Nov 13:46) Ranbaxy Laboratories (Analyst Meet / AGM - Conference Call 11-Nov 15:37) Ranbaxy Laboratories (Results - Analysis 10-Nov 16:29) Ranbaxy Laboratories reports net loss of Rs 439.20 crore in the September 2011 quarter (Results - Announcements 09-Nov 16:17) Ranbaxy Labs slumps on reporting Q3 net loss (Hot Pursuit 09-Nov 15:43) Ranbaxy Laboratories allots equity shares (Corporate News 12-Oct 15:27) Ranbaxy honored with NJBIA award for excellence in New Jersey Business Expansion (Corporate News 12-Oct 14:16) Ranbaxy Laboratories to announce Q3 results (Corporate News 10-Oct 14:16) Ranbaxy to extend Daiichi Sankyo Product reach to Pharmacists Across Italy (Corporate News 04-Oct 15:57) Ranbaxy Laboratories allots equity shares (Corporate News 04-Oct 15:38) Ranbaxy Lab in demand as Liptor release on schedule (Hot Pursuit 08-Sep 11:01) Ranbaxy UK launches esomeprazole (Corporate News 05-Sep 14:02) Daiichi Sankyo & Ranbaxy announce a new social contribution initiative encompassing India, Cameroon and Tanzania (Corporate News 31-Aug 14:02) Ranbaxy Laboratories appoints president & CFO (Corporate News 25-Aug 10:23) Ranbaxy introduces 'Volini Due' (Corporate News 12-Aug 15:42) Ranbaxy Laboratories (Results - Analysis 08-Aug 12:57) Ranbaxy Laboratories (Analyst Meet / AGM - Conference Call 08-Aug 12:52) Ranbaxy Laboratories reports net profit of Rs 150.37 crore in the June 2011 quarter (Results - Announcements 05-Aug 16:04) Ranbaxy Lab slips as Q2 PAT falls 25.3% (Hot Pursuit 05-Aug 14:54) Daiichi Sankyo and Ranbaxy to expand Hybrid Business Model in Mexico (Corporate News 02-Aug 12:28) Ranbaxy launches Letrozole tablets in UK, Romania & France (Corporate News 25-Jul 16:39) Ranbaxy Laboratories allots equity shares (Corporate News 12-Jul 17:13) Ranbaxy enters into a licensing agreement with Gilead Sciences (Corporate News 12-Jul 14:30) Ranbaxy Laboratories to announce Q2 results (Corporate News 04-Jul 14:37) Cadila Healthcare received final approval for the Donepezil Hydrochloride (Corporate News 12-May 18:11) Ranbaxy Laboratories (Results - Analysis 12-May 12:10) Better than expected Q1 earnings boost Ranbaxy (Hot Pursuit 11-May 09:31) Ranbaxy Laboratories reports net loss of Rs 52.91 crore in the March 2011 quarter (Results - Announcements 10-May 16:46) Ranbaxy corrects on buzz of potential $1 billion penalty (Hot Pursuit 05-May 11:33) Ranbaxy strengthens as US court rejects Mylan plea against Ranbaxy (Hot Pursuit 04-May 11:53) Ranbaxy launches Generic Olanzapine tablets in Spain (Corporate News 25-Apr 16:50) Ranbaxy Laboratories allots equity shares (Corporate News 11-Apr 15:04) Ranbaxy Laboratories to announce Q1 results (Corporate News 01-Apr 14:04) Ranbaxy tumbles on reports Mylan seeks to block Lipitor generic in US (Hot Pursuit 21-Mar 11:04) Ranbaxy Labs bucks trend on redeeming convertible bonds (Hot Pursuit 18-Mar 14:14) Daiichi Sankyo to leverage Ranbaxy's network to market its innovative products in Singapore (Corporate News 01-Mar 14:59) Ranbaxy Labs strengthens on US nod for a generic drug (Hot Pursuit 01-Mar 12:25) Ranbaxy Laboratories gets final approval for the Ondansetron (Corporate News 01-Mar 11:29) Ranbaxy Laboratories (Results - Analysis 23-Feb 16:46) Investors dump Ranbaxy Laboratories after weak sales forecast (Hot Pursuit 23-Feb 11:32) Ranbaxy tumbles on weak FY 2011 sales guidance (Hot Pursuit 22-Feb 16:00) Ranbaxy Laboratories net profit rises 100.83% in the year ended December 2010 (Results - Announcements 22-Feb 15:21) Ranbaxy Laboratories recommends dividend (Corporate News 22-Feb 14:49) Ranbaxy Laboratories to consider dividend (Corporate News 14-Feb 16:20) Ranbaxy signs MOU with Government of Yaroslavl Region, Russia (Corporate News 31-Jan 15:55) Ranbaxy Laboratories to announce financial results (Corporate News 28-Jan 14:48) Ranbaxy Laboratories' President & CFO resigns (Corporate News 27-Jan 09:38) Ranbaxy Laboratories allots equity shares (Corporate News 11-Jan 16:26) Ranbaxy gains on US FDA approval for a generic drug (Hot Pursuit 30-Nov 11:39) Ranbaxy recieves USFDA approval (Corporate News 30-Nov 09:59) Ranbaxy in the pink of health on US nod for Alzheimer's drug (Hot Pursuit 29-Nov 10:21) Ranbaxy Laboratories (Analyst Meet / AGM - Conference Call 13-Nov 15:45) Ranbaxy Laboratories (Results - Analysis 12-Nov 16:03) Ranbaxy Laboratories net profit rises 19.18% in the September 2010 quarter (Results - Announcements 11-Nov 10:56) Ranbaxy Laboratories scales 52-week high on healthy Q3 numbers (Hot Pursuit 11-Nov 10:39) Ranbaxy Laboratories allots equity shares (Corporate News 08-Oct 16:40) Ranbaxy gains on buzz of winning a court battle for anti-hepatitis B generic (Hot Pursuit 23-Sep 11:17) Buzz of receiving nod for generic drug in US strengthens Ranbaxy (Hot Pursuit 21-Sep 11:25) Ranbaxy jumps on setting up new facility in South Africa (Hot Pursuit 02-Sep 13:20) Ranbaxy sets up new manufacturing facility in South Africa (Corporate News 01-Sep 16:32) Ranbaxy Laboratories appoints Arun Sawhney as MD (Corporate News 20-Aug 16:35) Ranbaxy Laboratories (Analyst Meet / AGM - Conference Call 13-Aug 19:21) Ranbaxy Laboratories (Results - Analysis 13-Aug 16:14) Ranbaxy's board announces change in executive leadership (Corporate News 12-Aug 17:00) Ranbaxy Laboratories reports net loss of Rs 0.08 crore in the June 2010 quarter (Results - Announcements 12-Aug 15:51) Ranbaxy Laboratories' CEO & MD resigns (Corporate News 12-Aug 15:00) Daiichi Sankyo to leverage Ranbaxy's network to market Tavanic (Corporate News 21-Jul 14:38) Ranbaxy Laboratories to announce Q2 results (Corporate News 13-Jul 16:46) Ranbaxy Laboratories allots equity shares (Corporate News 12-Jul 17:29) Daiichi Sankyo and Ranbaxy to integrate new drug research and development system (Corporate News 02-Jul 12:15) Ranbaxy Laboratories launches antiplatelet agent Prasugrel in India (Corporate News 10-Jun 12:56) Ranbaxy launches generic Aaorvastatin, 'Lipogen' (Corporate News 08-Jun 15:16) Ranbaxy recovers after launching cholesterol drug in South Africa (Hot Pursuit 08-Jun 14:04) Ranbaxy launches Atorvastatin (Corporate News 21-May 14:48) Ranbaxy recovers on approval for generic drug in Canada (Hot Pursuit 21-May 12:58) Ranbaxy gets Health Canada approval for generic Lipitor (CSS News 21-May 12:37) Ranbaxy Laboratories (Analyst Meet / AGM - Conference Call 12-May 18:47) Ranbaxy Laboratories (Results - Analysis 12-May 16:34) Ranbaxy Laboratories reports net profit of Rs 871.80 crore in the March 2010 quarter (Results - Announcements 11-May 15:36) Ranbaxy gives away early gains (Hot Pursuit 11-May 15:31) Ranbaxy gets Health Canada approval for generic Zantac tablets (CSS News 11-May 09:21) Ranbaxy Laboratories allots equity shares (Corporate News 13-Apr 12:10) Ranbaxy Laboratories postpones board meeting (Corporate News 09-Apr 16:59) Ranbaxy Laboratories to announce Q1 results (Corporate News 05-Apr 16:40) Ranbaxy inches ahead on delisting buzz (Hot Pursuit 30-Mar 11:06) Ranbaxy & Pfenex announces collaboration for the development of biosimilar therapeutic protein (Corporate News 29-Mar 15:22) US tie-up lifts Ranbaxy Laboratories (Hot Pursuit 29-Mar 14:41) Ranbaxy gets UK MHRA nod for Fluxonazole solution (CSS News 23-Mar 10:10) Ranbaxy to market Ceftrizxone Sodium powder in United Kingdom (CSS News 22-Mar 12:35) Ranbaxy Lab announces settlement of Actos (Pioglitazone Hydrochloride) patent litigation (Corporate News 15-Mar 14:47) Ranbaxy settles patent litigation with Takeda Pharmaceuticals (CSS News 15-Mar 13:12) Ranbaxy rebounds on robust outlook (Hot Pursuit 12-Mar 10:17) Ranbaxy slips as regulator yet to give approval for Flomax generic (Hot Pursuit 03-Mar 09:48) Ranbaxy Laboratories (Analyst Meet / AGM - Conference Call 02-Mar 10:26) Ranbaxy Laboratories (Results - Analysis 27-Feb 17:14) Daiichi Sankyo group to expand its business scope in Japan (Corporate News 26-Feb 11:18) Ranbaxy hammered on tepid FY 2010 revenue growth forecast (Hot Pursuit 26-Feb 10:00) Ranbaxy Laboratories reports net profit of Rs 488.23 crore in the December 2009 quarter (Results - Announcements 25-Feb 15:45) Ranbaxy rebounds after turnaround FY 2009 results (Hot Pursuit 25-Feb 15:43) Ranbaxy Laboratories leads gainers in 'A' group (Hot Pursuit 16-Feb 16:07) New initiative lifts Ranbaxy Laboratories (Hot Pursuit 10-Feb 14:16) Daiichi Sankyo to launch innovator products in Mexico through Ranbaxy (Corporate News 10-Feb 12:45) Ranbaxy Labs in the pink of health (Hot Pursuit 28-Jan 10:25) Ranbaxy forays into vaccines arena (CSS News 19-Jan 15:45) Ranbaxy Laboratories signs agreement with Biovel Lifesciences (Corporate News 19-Jan 15:05) Ranbaxy Laboratories allots equity shares (Corporate News 13-Jan 17:32) Ranbaxy Laboratories strengthens (Hot Pursuit 08-Jan 15:24) Ranbaxy launches a new chemical entity, Lulifin (Luliconazole) (Corporate News 04-Jan 14:19) Ranbaxy to transfer stake in Ranbaxy (Guangzhou China) (Corporate News 29-Dec 13:54) Ranbaxy skids as US unit receives FDA warning (Hot Pursuit 29-Dec 10:23) US FDA issues warning letter to Ranbaxy's subsidiary manufacturing facility (CSS News 24-Dec 17:29) Ranbaxy's US subsidiary receives warning letter from USFDA (Corporate News 24-Dec 16:35) Ranbaxy in the pink of health after new drug launch in African countries (Hot Pursuit 21-Dec 13:51) Daiichi Sankyo to leverage Ranbaxy's presence in Africa for marketing Olmesartan (Corporate News 21-Dec 12:06) Ranbaxy and Nippon Chemiphar dissolve their joint venture 'Nihon Pharmaceutical Industry' in Japan (Corporate News 08-Dec 12:10) New drug launch in the US boosts Ranbaxy (Hot Pursuit 27-Nov 10:12) US nod for a generic drug lifts Ranbaxy Laboratories (Hot Pursuit 20-Nov 14:23) Ranbaxy strikes 52-week high on US nod for a generic drug (Hot Pursuit 19-Nov 12:30) Ranbaxy strengthens on WHO approval for AIDS drug (Hot Pursuit 13-Nov 09:57) Ranbaxy gains WHO pre-qualification (Corporate News 12-Nov 16:33) UK MHRA grants marketing approval for Ranbaxy's Valaciclovir tablets (CSS News 03-Nov 18:06) Ranbaxy Laboratories (Analyst Meet / AGM - Conference Call 27-Oct 12:26) Ranbaxy Laboratories (Results - Analysis 27-Oct 12:22) Ranbaxy Laboratories reports net profit of Rs 186.08 crore in the September 2009 quarter (Results - Announcements 26-Oct 10:39) Ranbaxy Lab flares up on turnaround Q3 numbers (Hot Pursuit 26-Oct 10:36) Ranbaxy Laboratories allots equity shares (Corporate News 12-Oct 16:11) Ranbaxy Labs shrugs off EU anti-trust raid (Hot Pursuit 08-Oct 10:31) Daiichi to leverage Ranbaxy's presence in Mexico for marketing & distribution (Corporate News 05-Oct 14:20) New license deal with South Korean firm strengthens Ranbaxy (Hot Pursuit 17-Sep 11:58) Ranbaxy in-licenses cosmetic product, Neuronox (Corporate News 17-Sep 11:06) Ranbaxy Laboratories to announce Q3 results (Corporate News 14-Sep 15:59) Ranbaxy Pharmaceuticals launches authorized generic version of Rocaltrol (Corporate News 03-Sep 11:58) Sankyo and Ranbaxy leverage new business model (Corporate News 01-Sep 14:01) Ranbaxy Lab strengthens on US nod for a generic drug (Hot Pursuit 25-Aug 11:24) Ranbaxy speeds up after USFDA approves drug (Hot Pursuit 24-Aug 12:57) Ranbaxy Laboratories receives final approval from USFDA (Corporate News 24-Aug 12:23) Ranbaxy receives final approval for Glycopyrrolate tablets (CSS News 21-Aug 10:19) Ranbaxy launches protein supplement (Corporate News 12-Aug 12:40) Ranbaxy Laboratories receives final approval from USFDA (Corporate News 11-Aug 15:56) Select pharma stocks rise as Govt steps up efforts to combat swine flu (Hot Pursuit 11-Aug 13:26) Ranbaxy launches Generic Losartan in Malaysia on day-one (Corporate News 04-Aug 14:50) Ranbaxy gains approval to market Ran-Ropinirole tablets in Canada (Corporate News 29-Jul 16:52) Ranbaxy gains on healthy Q2 results (Hot Pursuit 27-Jul 09:58) Ranbaxy Laboratories (Analyst Meet / AGM - Conference Call 25-Jul 19:10) Ranbaxy Laboratories (Results - Analysis 25-Jul 16:45) Ranbaxy Laboratories net profit rises 2746.40% in the June 2009 quarter (Results - Announcements 24-Jul 16:43) Ranbaxy Laboratories appoints CEO & MD (Corporate News 24-Jul 16:00) Ranbaxy's drug plant at Dewas receives GMP compliance approval (Corporate News 23-Jul 16:06) Health Canada grants marketing approval for Ranbaxy's Simvastatin Tablets (CSS News 21-Jul 11:49) Ranbaxy receives final approval for Ran-Simvastatin tablets (Corporate News 21-Jul 11:46) Ranbaxy receives UK MHRA nod for Topiramate tablets (CSS News 21-Jul 09:45) Ranbaxy receives final approval to manufacture and market Ran-Amlodipine tablets (Corporate News 20-Jul 16:06) Ranbaxy Laboratories allots equity shares (Corporate News 13-Jul 15:23) Ranbaxy Laboratories to announce Q2 results (Corporate News 06-Jul 15:22) Ranbaxy's Oxcarbaxepine solutions receives final nod from US FDA (CSS News 02-Jul 10:43) US woes hit Ranbaxy Lab (Hot Pursuit 26-Jun 14:51) UK MHRA grants marketing approval for Ranbaxy's Losartan Potassium tablets (CSS News 23-Jun 15:51) Rally in Ranbaxy fizzles out (Hot Pursuit 26-May 11:29) Larsen & Toubro, Ranbaxy Laboratories may see action (Market Commentary - Stock Alert 26-May 09:15) Change in top management boosts Ranbaxy (Hot Pursuit 25-May 11:08) Ranbaxy Laboratories' chairman, CEO & MD resigns (Corporate News 25-May 09:51) Ranbaxy Laboratories acquires brands from Ochoa Laboratories (Corporate News 22-May 11:26) Local acquisition boosts Ranbaxy Laboratories (Hot Pursuit 22-May 10:22) Ranbaxy spurts as investors await rupee windfall (Hot Pursuit 21-May 13:25) Ranbaxy's subsidiary in Germany to provide generic medicines in Germany (Corporate News 06-May 16:50) Ranbaxy commences phase-III clinical trials for its new anti-malarial molecule (Corporate News 04-May 15:05) Ranbaxy voluntarily recalls Nitrofurantoin capsules in U.S. (Corporate News 02-May 12:15) Ranbaxy Laboratories (Analyst Meet / AGM - Conference Call 27-Apr 15:06) Ranbaxy Laboratories (Results - Analysis 27-Apr 15:03) Hefty forex losses is a bitter pill for Ranbaxy (Hot Pursuit 27-Apr 11:47) Ranbaxy Laboratories reports net loss of Rs 777.78 crore in the March 2009 quarter (Results - Announcements 24-Apr 17:49) Ranbaxy Laboratories to announce Q1 results (Corporate News 16-Apr 10:48) Ranbaxy falters on buzz of huge forex losses (Hot Pursuit 16-Apr 10:40) Battered Ranbaxy Lab in recovery mode (Hot Pursuit 01-Apr 11:53) Ranbaxy to launch Daiichi Sankyo's innovative antihypertensive, Olvance in India (Corporate News 31-Mar 11:08) Ranbaxy gains final approval for Topirimate tablets (Corporate News 30-Mar 12:12) Ranbaxy Laboratories appoints director (Corporate News 27-Mar 16:00) Ranbaxy Laboratories receives approval from TGA-Australia (Corporate News 25-Mar 14:26) Ranbaxy Lab in the pink of health (Hot Pursuit 23-Mar 14:36) Ranbaxy's Paonta Sahib plant receives MHRA, UK and TGA, Australia approvals (Corporate News 23-Mar 11:59) Ranbaxy Laboratories to consider financial results (Corporate News 18-Mar 15:28) Weak market takes its toll on Ranbaxy (Hot Pursuit 09-Mar 11:35) Ranbaxy gains final approval from USFDA (Corporate News 09-Mar 10:24) Ranbaxy gets TGA-Australia approval (Corporate News 06-Mar 15:03) Ranbaxy receives USFDA approval (Corporate News 05-Mar 15:34) Ranbaxy tumbles as drug quality issue haunts again (Hot Pursuit 05-Mar 13:07) Ranbaxy tumbles as US FDA says HP plant falsified data (Hot Pursuit 26-Feb 10:29) Ranbaxy Lab strengthens on block deal (Hot Pursuit 17-Feb 11:24) US nod for generics drug boosts Ranbaxy (Hot Pursuit 11-Feb 10:24) Ranbaxy Laboratories (Analyst Meet / AGM - Conference Call 23-Jan 17:07) Ranbaxy Laboratories (Results - Analysis 23-Jan 14:12) Bitter pill for Ranbaxy Laboratories on dismal earnings (Hot Pursuit 23-Jan 10:21) Ranbaxy Laboratories reports net loss of Rs 806.55 crore in the December 2008 quarter (Results - Announcements 22-Jan 17:46) Ranbaxy's drug discovery team achieves significant landmark in GSK Research collaboration (Corporate News 09-Jan 11:48) Ranbaxy slides on missing the deadline for key drug launch in US (Hot Pursuit 02-Jan 10:08) Ranbaxy Laboratories to consider Q4 results (Corporate News 01-Jan 14:37) Unitech, Ranbaxy Laboratories, Jaiprakash Associates may see action (Market Commentary - Stock Alert 22-Dec 09:14) Ranbaxy Laboratories' director resigns (Corporate News 19-Dec 15:39) Ranbaxy reconstitutes board of directors following strategic alliance with Japan's Daiichi Sankyo (Corporate News 19-Dec 14:58) Ranbaxy Laboratories' director resigns (Corporate News 15-Dec 17:35) Ranbaxy slips on sharp slide in US sales (Hot Pursuit 12-Dec 11:33) Ranbaxy strengthens on tie up with US firm (Hot Pursuit 04-Dec 09:49) Ranbaxy to market USFDA approved drug for treatment of brain tumor in India (Corporate News 03-Dec 15:59) Ranbaxy and Daiichi Sankyo successfully completes landmark deal (Corporate News 07-Nov 12:29) Ranbaxy Laboratories (Results - Analysis 03-Nov 12:11) Ranbaxy Laboratories reports net loss of Rs 352.93 crore in the September 2008 quarter (Results - Announcements 31-Oct 17:33) Ranbaxy Laboratories' director resigns (Corporate News 31-Oct 16:42) Ranbaxy receives US FDA approval for Risperidone tablets (CSS News 31-Oct 09:44) Eight Sensex stocks stoop to their lows (Hot Pursuit 27-Oct 16:17) Ranbaxy Laboratories to announce Q3 results (Corporate News 21-Oct 15:59) Ranbaxy Laboratories to allot equity shares & warrants (Corporate News 20-Oct 15:29) Ranbaxy achieves significant landmark in anti-malarial research (Corporate News 17-Oct 10:46) Ranbaxy Laboratories allots equity shares (Corporate News 13-Oct 16:11) Ranbaxy achieves another significant milestone in GSK research inflammation candidate (Corporate News 13-Oct 11:42) Ranbaxy bucks weak trend (Hot Pursuit 10-Oct 15:03) Ranbaxy Lab in the pink of health (Hot Pursuit 08-Oct 13:27) Ranbaxy leads gainers in ‘A’ group (Hot Pursuit 03-Oct 16:56) Ranbaxy Lab spurts (Hot Pursuit 03-Oct 10:33) Aurobindo gets final approval for Cyclobenzaprine Hydrochloride tablets (CSS News 27-Sep 11:59) Ranbaxy Laboratories inches ahead (Hot Pursuit 24-Sep 14:13) Ranbaxy Laboratories leads losers in BSE Sensex (Hot Pursuit 23-Sep 15:14) Ranbaxy Laboratories tumbles on Canadian trouble (Hot Pursuit 23-Sep 11:14) Ranbaxy retains former New York City Mayor Rudy Giuliani to lead team in resolution of issues raised by USFDA (Corporate News 18-Sep 10:15) Ranbaxy slumps on US ban (Hot Pursuit 17-Sep 10:02) Ranbaxy granted approval by MHRA for Tizanidine Hydrochloride Tablets (CSS News 10-Sep 16:28) Ranbaxy tumbles as open offer ends (Hot Pursuit 05-Sep 15:26) Ranbaxy tumbles as open offer nears end (Hot Pursuit 02-Sep 11:21) Ranbaxy Laboratories slides (Hot Pursuit 25-Aug 13:42) Ranbaxy inches ahead as govt approves Daiichi deal (Hot Pursuit 07-Aug 10:38) Ranbaxy Laboratories (Analyst Meet / AGM - Conference Call 01-Aug 19:46) WHO approves Ranbaxy's ARV drug in its pre-qualification list (Corporate News 01-Aug 14:14) Ranbaxy Laboratories (Results - Analysis 30-Jul 12:53) Ranbaxy Laboratories net profit declines 91.85% in the June 2008 quarter (Results - Announcements 29-Jul 14:28) Ranbaxy slips on flat Q2 results (Hot Pursuit 29-Jul 13:43) Ranbaxy launches Omeprazole 40 mg capsules (Corporate News 28-Jul 11:39) Ranbaxy Laboratories launches Generic Amlodipine tablets on day-1 in Japan (Corporate News 23-Jul 14:55) Ranbaxy wins UK SFO case (Corporate News 22-Jul 12:06) Ranbaxy Laboratories to announce Q2 results (Corporate News 18-Jul 16:19) Daiichi Sankyo & Ranbaxy announces confirm deal is binding & final (Corporate News 17-Jul 10:07) Ranbaxy strikes back (Hot Pursuit 16-Jul 10:15) Ranbaxy Laboratories hammered (Hot Pursuit 15-Jul 12:06) Ranbaxy Laboratories to issue equity shares & warrants (Corporate News 15-Jul 10:27) Ranbaxy slumps on US court action worries (Hot Pursuit 14-Jul 11:11) Ranbaxy Laboratories allots equity shares (Corporate News 10-Jul 15:57) Ranbaxy Laboratories strengthens (Hot Pursuit 07-Jul 09:55) Ranbaxy Laboratories receives USFDA approval (Corporate News 25-Jun 14:19) Ranbaxy gets a boost from US FDA approval for genetics drug (Hot Pursuit 25-Jun 14:14) Ranbaxy Granted Final Approval For Cetrizine Hydrochloride Syrup (CSS News 23-Jun 15:11) Ranbaxy tumbles on delay in launch of generic version of Pfizer’s blockbuster drug (Hot Pursuit 19-Jun 10:17) Ranbaxy Laboratories enters into agreement with Pfizer Inc. (Corporate News 18-Jun 16:42) Ranbaxy scales 52-week high on buzz of upward revision of open offer (Hot Pursuit 18-Jun 12:08) Ranbaxy in demand on buzz of counter offer by Pfizer (Hot Pursuit 13-Jun 10:11) Ranbaxy Laboratories (Analyst Meet / AGM - Conference Call 12-Jun 10:26) Ranbaxy Laboratories to issue shares & warrants (Corporate News 11-Jun 14:21) Ranbaxy Laboratories and Daiichi Sankyo Company enter into share purchase and share subscription agreement (Corporate News 11-Jun 14:01) Volatility rules the roost at Ranbaxy counter (Hot Pursuit 11-Jun 13:16) Ranbaxy hits 52-week high on buzz of change of guard (Hot Pursuit 11-Jun 11:49) Marketing Authorisations Received By Indian Pharma Companies In April’08 (CSS News 05-Jun 14:34) Ranbaxy Laboratories launches business operation in Yemen (Corporate News 21-May 16:03) Ranbaxy Receives Final Approval For Cyclobenzaprine Hydrochloride Tablets (CSS News 14-May 12:24) Marketing Authorisations Received By Indian Pharma Companies In March’08 (CSS News 14-May 12:21) Ranbaxy in the pink of health after drug discovery tie-up (Hot Pursuit 12-May 15:10) Ranbaxy & Merck signs anti-infective drug discovery & development agreement (Corporate News 12-May 14:20) US FDA nod for new drug boosts Ranbaxy (Hot Pursuit 28-Apr 10:56) Ranbaxy received final approval for Cetirizine Hydrochloride Oral Solution (CSS News 26-Apr 11:06) Ranbaxy Laboratories receives USFDA approval (Corporate News 25-Apr 17:05) Ranbaxy Laboratories (Analyst Meet / AGM - Conference Call 23-Apr 14:18) Ranbaxy Laboratories (Results - Analysis 23-Apr 12:54) Solrex Pharmaceuticals Company acquires equity shares of Orchid Chemicals & Pharmaceuticals (Corporate News 22-Apr 14:15) Ranbaxy & Orchid enters into business alliance agreement (Corporate News 22-Apr 14:07) Ranbaxy Laboratories net profit declines 10.29% in the March 2008 quarter (Results - Announcements 22-Apr 13:55) Ranbaxy Pharmaceuticals enters into several agreements with AstraZeneca (Corporate News 15-Apr 13:51) Ranbaxy Laboratories in the pink of health after settlement of patent dispute (Hot Pursuit 15-Apr 12:30) Ranbaxy Laboratories to announce Q1 results (Corporate News 11-Apr 17:17) Ranbaxy Laboratories allots equity shares (Corporate News 09-Apr 14:04) Ranbaxy Laboratories slides (Hot Pursuit 09-Apr 13:04) Ranbaxy Laboratories enters into collaborative research agreement with DBT, New Delhi (Corporate News 09-Apr 12:18) Japanese approval for drug does not benefit Ranbaxy (Hot Pursuit 08-Apr 13:12) Ranbaxy becomes first foreign generic company to develop generic product independently (Corporate News 08-Apr 12:27) Ranbaxy launches Bonista in Rs 220 crore Osteoporosis market (CSS News 03-Apr 14:53) Ranbaxy Laboratories launches worlds first Bio-generic recombinant injectible for the treatment of Osteoporosis in India (Corporate News 03-Apr 12:21) Ranbaxy Laboratories inches ahead (Hot Pursuit 03-Apr 11:58) Ranbaxy Laboratories recommends final dividend (Corporate News 28-Mar 12:05) Ranbaxy Laboratories to announce financial results (Corporate News 18-Mar 15:35) Ranbaxy Laboratories in the pink of health (Hot Pursuit 18-Mar 14:48) Ranbaxy to introduce Inersan brand in India & Nepal (Corporate News 18-Mar 14:00) BSE Healthcare index in the pink of health (Hot Pursuit 03-Mar 14:07) Ranbaxy Laboratories' board clears scheme of de-merger of New Drug Discovery Research unit (Corporate News 19-Feb 15:14) Ranbaxy Laboratories gains on restructuring plan (Hot Pursuit 14-Feb 11:33) Ranbaxy Laboratories to consider scheme of arrangement (Corporate News 13-Feb 15:44) Ranbaxy received tentative approval for Esomeprazole Magnesium DR Capsules (CSS News 07-Feb 12:50) Ranbaxy Laboratories receives US FDA approval (Corporate News 07-Feb 12:18) Ranbaxy slips despite US FDA approval for new drug (Hot Pursuit 07-Feb 10:22) Ranbaxy Laboratories receives approval from USFDA to manufacture & market cefuroxime axetil (Corporate News 06-Feb 16:00) Aurobindo received final approval for Gabapentin Capsules (CSS News 05-Feb 11:27) Aurobindo receives tentative approval for Sumatriptan Succinate Tablets (CSS News 01-Feb 10:38) Settlement of patent litigation lifts Ranbaxy (Hot Pursuit 21-Jan 11:05) Ranbaxy announces settlement of possible Imitrex litigation (Corporate News 21-Jan 11:02) Ranbaxy Laboratories leads gainers in 'A' group (Hot Pursuit 18-Jan 16:40) Ranbaxy spurts (Hot Pursuit 18-Jan 15:19) Ranbaxy Laboratories (Results - Analysis 18-Jan 15:06) Ranbaxy Laboratories (Analyst Meet / AGM - Conference Call 18-Jan 14:58) Ranbaxy defers demerger of New Drug Discovery Research unit (CSS News 17-Jan 14:55) Ranbaxy Laboratories drops after Q4 results (Hot Pursuit 17-Jan 14:46) Ranbaxy Laboratories net profit declines 65.20% in the December 2007 quarter (Results - Announcements 17-Jan 13:57) Ranbaxy can receive US$ 100 million milestone payments (CSS News 17-Jan 13:51) Ranbaxy Laboratories to consider scheme of arrangement (Corporate News 12-Jan 11:45) Ranbaxy enters the Chyawanprash market (Corporate News 11-Jan 17:19) Ranbaxy Laboratories allots equity shares (Corporate News 10-Jan 12:35) Ranbaxy Laboratories' chief mentor & executive vice chairman retires (Corporate News 01-Jan 12:01) Ranbaxy Laboratories receives final approval from US FDA (Corporate News 31-Dec 14:24) Ranbaxy got the final approval for Ranitidine Oral Solution (Corporate News 15-Dec 14:33) Ranbaxy Laboratories gains on US FDA nod for a generic drug (Hot Pursuit 07-Dec 14:25) Ranbaxy Laboratories receives approval to manufacture & market ARV combination (Corporate News 06-Dec 16:09) Zenotech Laboratories allots equity shares (Corporate News 27-Nov 18:11) Ranbaxy gains on Canadian approval for new drug (Hot Pursuit 22-Nov 10:07) Ranbaxy Laboratories receives approval to manufacture and market tamsulosin hydrochloride capsules (Corporate News 21-Nov 15:50) Ranbaxy drops on recalling a drug from US market (Hot Pursuit 16-Nov 13:11) Ranbaxy slips despite prostate drug patent case settlement (Hot Pursuit 08-Nov 14:40) Ranbaxy Laboratories enters into agreement with Astellas / Boehringer Ingelheim (Corporate News 08-Nov 12:57) Record date for Ranbaxy Laboratories interim dividend is 02 November 2007 (Market Beat - Reports 01-Nov 12:21) Ranbaxy Laboratories receives tentative approval from US FDA (Corporate News 29-Oct 15:53) Ranbaxy Laboratories to launch osonase aqueous nasal spray (Corporate News 24-Oct 13:51) Ranbaxy Laboratories receives approval to market ran (Corporate News 22-Oct 12:17) Ranbaxy Laboratories (Results - Analysis 19-Oct 15:00) Ranbaxy Laboratories (Analyst Meet / AGM - Conference Call 19-Oct 09:56) Ranbaxy Laboratories receives in-principle approval from the board (Corporate News 18-Oct 15:24) Ranbaxy Laboratories declares interim dividend (Corporate News 18-Oct 14:43) Ranbaxy Laboratories net profit rises 72.81% in the September 2007 quarter (Results - Announcements 18-Oct 14:34) Ranbaxy Laboratories allots equity shares (Corporate News 10-Oct 16:51) Ranbaxy Laboratories to announce Q3 results (Corporate News 08-Oct 17:14) Ranbaxy Laboratories receives U.S. FDA final approval (Corporate News 04-Oct 14:08) Prospects of a sibling bring joy to Ranbaxy Laboratories (Hot Pursuit 04-Oct 10:56) Ranbaxy forays into liver cancer market (Corporate News 24-Sep 15:56) Ranbaxy Laboratories receives WHO pre-qualification (Corporate News 10-Sep 12:30) Ranbaxy Laboratories receives US FDA approval (Corporate News 06-Sep 16:30) Ranbaxy gains on putting bid for acquiring US firm (Hot Pursuit 06-Sep 10:25) Ranbaxy Laboratories receives USFDA approval (Corporate News 30-Aug 16:24) Ranbaxy Laboratories launches urology drug Roliflo OD (Corporate News 22-Aug 16:30) Ranbaxy Laboratories receives US FDA approval (Corporate News 20-Aug 17:20) Ranbaxy's BP drops as Novartis slaps a suit (Hot Pursuit 16-Aug 14:46) Ranbaxy Laboratories commercialises its first authorized generic Isoptin SR in US (Corporate News 30-Jul 15:09) Ranbaxy Laboratories and GSK enters into an agreement (Corporate News 26-Jul 12:18) Foes-turned-friends: Settlement with Glaxo is a booster dose for Ranbaxy (Hot Pursuit 26-Jul 12:10) Ranbaxy Laboratories (Analyst Meet / AGM - Conference Call 20-Jul 09:45) Ranbaxy Laboratories (Results - Analysis 20-Jul 09:41) Relief for Ranbaxy Laboratories on getting Q2 formula right (Hot Pursuit 19-Jul 14:59) Ranbaxy Laboratories net profit rises 191.65% in the June 2007 quarter (Results - Announcements 19-Jul 12:50) Ranbaxy Laboratories to close one of its manufacturing facility (Corporate News 13-Jul 10:47) Ranbaxy Laboratories allots equity shares (Corporate News 12-Jul 15:12) Ranbaxy Laboratories receives final US FDA approval (Corporate News 10-Jul 15:29) Ranbaxy Pharmaceuticals Inc launches Pravastatin Sodium 80 mg tablets (Corporate News 25-Jun 12:52) Ranbaxy Laboratories' Tamsulosin capsusles get tentative nod from US FDA (Corporate News 22-Jun 12:42) Ranbaxy Laboratories excited on US okay for stress-buster (Hot Pursuit 21-Jun 10:41) Ranbaxy Laboratories receives USFDA approval (Corporate News 20-Jun 17:59) Ranbaxy Laboratories appoints additional director (Corporate News 31-May 14:23) Ranbaxy Labs gains on bagging US rights for dermatology products (Hot Pursuit 28-May 14:28) Ranbaxy Labs gets approval for Ran-Pravastatin (Corporate News 21-May 12:19) Ranbaxy gets tentative nod for Fexofenadine (Corporate News 18-May 12:41) Ranbaxy to acquire Be-Tabs Pharma (Corporate News 08-May 15:56) Ranbaxy Labs gains on Brazil's move on anti-AIDS drug (Hot Pursuit 07-May 15:36) Ranbaxy Laboratories (Analyst Meet / AGM - Conference Call 28-Apr 18:20) Ranbaxy Laboratories: (Results - Analysis 28-Apr 18:18) Ranbaxy pares losses on strong Q1 numbers (Hot Pursuit 27-Apr 14:48) Ranbaxy Laboratories net profit rises 129.46% in the March 2007 quarter (Results - Announcements 27-Apr 12:56) Ranbaxy gains on US FDA nod, 180-day monopoly for drug (Hot Pursuit 25-Apr 12:22) Ranbaxy Lab. gets US FDA nod for Pravastatin Sodium Tablets (Corporate News 25-Apr 11:14) Ranbaxy under pressure (Hot Pursuit 12-Apr 13:58) Ranbaxy Labs gets nod for Cefprozil Tablets (Corporate News 12-Apr 13:45) Ranbaxy Labs to consider March 2007 Q1 results (Corporate News 11-Apr 17:16) Record date for Ranbaxy Laboratories second interim dividend is 05 April 2007 (Market Beat - Reports 04-Apr 09:35) Terapia Ranbaxy gets certification for Good Manufacturing Practice renewal (Corporate News 03-Apr 16:26) Ranbaxy to test new respiratory drug (Corporate News 02-Apr 11:58) Ranbaxy Lab to pay second interim dividend (Corporate News 29-Mar 12:47) Wockhardt rallies most in 'A' group (Hot Pursuit 28-Mar 16:37) Ranbaxy Labs spurts on quitting race for Merck's generics business (Hot Pursuit 20-Mar 15:27) Ranbaxy Labs fixes record date on 31 December 2007 (Corporate News 16-Mar 17:24) Ranbaxy Labs marches ahead on tentative US FDA okay to insomnia drug (Hot Pursuit 16-Mar 15:46) Ranbaxy Labs gets tentative nod for zolpidem (Corporate News 16-Mar 12:10) Ranbaxy Labs to consider December 2006 ended accounts (Corporate News 15-Mar 11:23) Ranbaxy Labs makes non-binding bid (Corporate News 14-Mar 09:56) Ranbaxy drops as Pfizer takes patent dispute to court (Hot Pursuit 13-Mar 12:58) Ranbaxy's poor run continues (Hot Pursuit 07-Mar 15:49) Ranbaxy worst hit among Sensex pack (Hot Pursuit 05-Mar 14:03) Ranbaxy grants exclusive license to PPD (Corporate News 01-Mar 12:10) Ranbaxy gets RRA's nod (Corporate News 22-Feb 12:52) Ranbaxy shaky on takeover concerns (Hot Pursuit 21-Feb 14:49) Promoters not to sell stake in Ranbaxy (Corporate News 21-Feb 12:09) Ranbaxy Labs defiant (Hot Pursuit 20-Feb 15:24) US officials search New Jersey offices of Ranbaxy (Corporate News 16-Feb 15:07) Ranbaxy launches generic Lipitor in Denmark (Corporate News 13-Feb 11:23) Ranbaxy gets US-FDA nod for amoxicillin (Corporate News 07-Feb 14:48) Ranbaxy Labs signs pact with Zenotech Labs (Corporate News 07-Feb 14:05) R&D pact with GSK supports Ranbaxy (Hot Pursuit 06-Feb 13:37) Ranbaxy Labs signs a pact with GSK, Uk (Corporate News 06-Feb 13:33) Ranbaxy Laboratories (Analyst Meet / AGM - Conference Call 23-Jan 15:29) Ranbaxy Laboratories (Results - Analysis 19-Jan 15:39) Ranbaxy Laboratories (Analyst Meet / AGM - Analyst Meet 19-Jan 10:42) Ranbaxy Labs mulls to acquire 14.9% in Krebs Biochem (Corporate News 18-Jan 14:25) Ranbaxy: Results euphoria wanes (Hot Pursuit 18-Jan 14:23) Ranbaxy Laboratories net profit at Rs 139.07 crore in Deember 2006 quarter (Results - Announcements 18-Jan 13:36) Ranbaxy seen reporting a surge in bottomline in December 2006 quarter (Market Beat - Reports 16-Jan 19:58) Ranbaxy firms up on entering fray for Merck’s generics biz (Hot Pursuit 09-Jan 11:16) US FDA nod for hypertension drug boosts Ranbaxy (Hot Pursuit 03-Jan 13:02) US FDA clears Ranbaxy's atenolol tabs (Corporate News 02-Jan 14:04) US FDA grants Ranbaxy marketing rights for Simvastatin (Corporate News 21-Dec 16:02) Aussie court offers relief to Ranbaxy in Pfizer tiff (Corporate News 21-Dec 09:50) US FDA nod for a generics drug boosts Ranbaxy (Hot Pursuit 18-Dec 13:58) US FDA nod for anti-infective drug thrills Ranbaxy (Hot Pursuit 15-Dec 10:42) US FDA approves Ranbaxy's Cefprozil tablets (Corporate News 14-Dec 15:50) Ranbaxy Lab acquires Be-Tabs Pharmaceuticals of South Africa (Corporate News 01-Dec 15:34) Ranbaxy eyeing for $2 billion sales in 2007 (Corporate News 24-Nov 14:25) Ranbaxy's 180 days exclusivity for Simvastatin affirmed by US Court (Corporate News 15-Nov 20:52) Ranbaxy Labs rises as US court upholds drug sales exclusivity (Hot Pursuit 15-Nov 14:57) US Court of Appeals affirm earlier decision on Simvastatin (Corporate News 15-Nov 13:07) Wockhardt, Ranbaxy may edge higher (Market Commentary - Stock Alert 07-Nov 09:43) Ranabaxy gets USFDA nod for Cetirizine Hydrochloride syrup (Corporate News 03-Nov 14:32) Ranbaxy signs licensing agreement with Swiss Company (Corporate News 23-Oct 14:30) Ranbaxy Laboratories (Results - Analysis 20-Oct 20:59) Ranbaxy Laboratories Q3 net at Rs 97.31 crore (Results - Announcements 19-Oct 15:37) Ranbaxy’s Canadian subsidiary to market fentanyl (Corporate News 06-Oct 14:03) Ranbaxy crawls up on tie-up to sell product in Canada (Hot Pursuit 06-Oct 13:19) Ranbaxy launches generic Atorvastatin in Malaysia (Corporate News 27-Sep 13:57) Ranbaxy climbs as FDA okays generic drug (Hot Pursuit 21-Sep 13:02) Ranbaxy gets USFDA approval for Furosemide Tablets (Corporate News 21-Sep 12:01) Ranbaxy in-licensing agreement with Ethypharm India (Corporate News 19-Sep 10:26) Ranbaxy launches new product to counter asthma (Corporate News 12-Sep 13:37) Ranbaxy overturns (Hot Pursuit 11-Sep 12:48) Ranbaxy gets USFDA nod for Loperamide Hydrochloride, Simethicone tablets (Corporate News 11-Sep 12:25) Ranbaxy upbeat on favourable court verdict (Hot Pursuit 30-Aug 12:20) Ranbaxy wins two additional Atorvastatin patents in Norway (Corporate News 30-Aug 11:26) Ranbaxy Labs crawls up on new drug launch (Hot Pursuit 18-Aug 15:37) Ranbaxy launches Soliten for treatment of chronic urology disorder (Corporate News 18-Aug 14:51) Kabra Extrusiontechnik trots ahead (Hot Pursuit 11-Aug 10:56) Ranbaxy crawls up on decision to sell Irish unit (Hot Pursuit 11-Aug 10:56) Ranbaxy Laboratories to divest manufacturing unit of Ranbaxy Ireland (Corporate News 11-Aug 09:44) Ranbaxy Labs edges up on US FDA nod to Resperidone (Hot Pursuit 07-Aug 10:06) Ranbaxy may gain on US FDA nod for risperidone (Market Commentary - Stock Alert 07-Aug 09:42) Ranbaxy gets tentative USFDA approval for Risperidone (Corporate News 05-Aug 13:54) Ranbaxy invalidates Pfizer’s '995 Lipitor U.S. patent (Corporate News 03-Aug 12:38) Ranbaxy may slip as it loses patent case on Lipitor (Market Commentary - Stock Alert 03-Aug 09:34) Ranbaxy Laboratories (Results - Analysis 21-Jul 17:57) Ranbaxy Laboratories Q2 net at Rs 99.83 crore (Results - Announcements 20-Jul 14:39) Ranbaxy Laboratories on recovery trail (Hot Pursuit 20-Jul 12:24) Ranbaxy’s arm signs licensing agreement for the Canadian market (Corporate News 19-Jul 16:52) Ranbaxy gains on Spanish conquest (Hot Pursuit 19-Jul 12:32) Ranbaxy to acquire generic business of Glaxosmithkline in Spain (Corporate News 18-Jul 17:04) Ranbaxy launches generic Clarithromycin and Terbinafine tablets (Corporate News 17-Jul 14:31) NSE reduces market lots for some derivatives (Market Beat - Reports 05-Jul 14:53) Ranbaxy gets USFDA nod to market Cefprozil Suspension (Corporate News 01-Jul 11:29) Ranbaxy may slip on UK court ruling on Lipitor generics (Market Commentary - Stock Alert 29-Jun 09:48) Ranbaxy receives USFDA approval for Simvastatin tablets (Corporate News 26-Jun 09:53) Ranbaxy to market epilepsy drug in US (Corporate News 09-Jun 15:07) Ranbaxy improves in a weak market (Hot Pursuit 08-Jun 13:27) Ranbaxy’s arm buys 96.7% stake in Romanian company (Corporate News 08-Jun 11:35) Ranbaxy's US subsidiary partners with Zenotech (Corporate News 07-Jun 15:38) Ranbaxy gets nod from USFDA for Doxycycline tablets (Corporate News 02-Jun 13:55) WHO includes four ARVs of Ranbaxy (Corporate News 24-May 16:01) Ranbaxy in-licencsing agreement with Ethypharm-France (Corporate News 24-May 14:56) Ranbaxy glimmers on anti-asthma drug deal (Hot Pursuit 17-May 14:44) Ranbaxy to launch anti-asthma drug in India (Corporate News 17-May 13:13) Dr Reddy’s Lab, Ranbaxy elated on US court ruling on Merck's generic drug (Hot Pursuit 02-May 14:37) Ranabaxy denies R&D hive off idea (Corporate News 21-Apr 16:13) Ranbaxy surges on proposal to hive off R&D division (Hot Pursuit 21-Apr 11:08) Ranbaxy Laboratories (Results - Analysis 20-Apr 21:05) Ranbaxy Laboratories (Analyst Meet / AGM - Conference Call 20-Apr 11:44) Ranbaxy Q1 net at Rs 71.40 crore (Results - Announcements 19-Apr 15:37) Ranbaxy’s UK arm under attack (Corporate News 05-Apr 14:36) European acquisition binge fuels Ranbaxy (Hot Pursuit 05-Apr 14:09) Rally in Ranbaxy accelerates on overseas acquisition (Hot Pursuit 30-Mar 10:52) Big ticket acquisition boosts Ranbaxy (Hot Pursuit 29-Mar 13:49) Ranbaxy to acquire Terapia SA (Corporate News 29-Mar 12:00) Ranbaxy acquires GlaxoSmithKline’s Italian business (Corporate News 28-Mar 10:20) Italian acquisition spurs Ranbaxy (Hot Pursuit 28-Mar 10:11) Ranbaxy rebounds (Hot Pursuit 24-Mar 15:16) Ranbaxy Laboratories launches Osonide Inhaler (Corporate News 24-Mar 13:59) Ranbaxy Laboratories purchases Senetek's auto-injector (Corporate News 21-Mar 12:06) Ranbaxy Laboratories ties up with Zenotech Laboratories (Corporate News 09-Mar 16:37) Dr Reddy's Labs gains as Ranbaxy loses (Hot Pursuit 16-Feb 10:48) Ranbaxy Labs launches $ 400 million FCCB issue (Corporate News 16-Feb 10:01) Ranbaxy up on Betapharm bid (Hot Pursuit 08-Feb 13:13) Joint venture helps Ranbaxy sustain momentum (Hot Pursuit 06-Feb 14:14) Ranbaxy to form joint venture with S African firm (Corporate News 06-Feb 13:57) Ranbaxy Laboratories (Analyst Meet / AGM - Conference Call 21-Jan 16:20) Ranbaxy Laboratories (Results - Analysis 19-Jan 17:46) RANBAXY YEAR 2005 GLOBAL SALES AT USD 1178 MN (Press Releases 19-Jan 11:33) Ranbaxy takes fresh guard after a forgettable Q4 (Hot Pursuit 19-Jan 10:48) Ranbaxy Laboratories Q4 net profit at Rs 68.60 crore (Results - Announcements 18-Jan 15:48) BRIAN TEMPEST PROMOTED AS CHIEF MENTOR AND EXECUTIVE VICE CHAIRMAN MALVINDER MOHAN SINGH TAKES CHARGE AS CEO AND MD IN SMOOTH SUCCESSION PLAN (Press Releases 18-Jan 11:19) Marketing pact rescues Ranbaxy (Hot Pursuit 10-Jan 14:45) Ranbaxy reaches marketing agreement with Swiss firm (Corporate News 10-Jan 14:02) Ranbaxy Laboratories Limited Announces an Agreement with Cephalon Regarding Settlement of Provigil® Patent Litigation (Press Releases 23-Dec 11:39) Cephalon permits Ranbaxy to sell generic version of Provigil (Corporate News 23-Dec 10:50) Ranbaxy loses Lipitor law suit (Corporate News 17-Dec 16:22) PROMISING NEW ANTIMALARIAL DRUG DEMONSTRATES SIGNIFICANT PARASITE REDUCTION IN PATIENTS (Press Releases 13-Dec 14:25) RANBAXY READY TO HELP THE U.S. GOVERNMENT (Press Releases 02-Dec 14:47) RANBAXY LAUNCHES TWO NEW ANTI-HIV PRODUCTS IN INDIA ON WORLD AIDS DAY (Press Releases 01-Dec 14:26) RANBAXY LAUNCHES TWO NEW ANTI-HIV PRODUCTS IN INDIA ON WORLD AIDS DAY (Press Releases 30-Nov 10:28) RANBAXY HONOURS INDIAN SCIENTISTS FOR OUTSTANDING RESEARCH CONTRIBUTIONS (Press Releases 28-Nov 09:37) US COURT OF APPEALS UPHOLDS PRELIMINARY INJUNCTION AGAINST RANBAXY, ENJOINING COMPANY FROM MARKETING QUINAPRIL HCL TABLETS (Press Releases 23-Nov 10:16) Adverse US court ruling on generics drug hits Ranbaxy (Hot Pursuit 23-Nov 10:03) Ranbaxy slips on lawsuit by AstraZeneca for patent protection (Hot Pursuit 22-Nov 13:40) Ranbaxy in focus (Hot Pursuit 17-Nov 12:31) Ranbaxy Laboratories extends gains (Hot Pursuit 14-Nov 11:36) RANBAXY CONSOLIDATES RELATIONSHIP WITH JAPAN JV PARTNERNIPPON CHEMIPHAR (Press Releases 12-Nov 10:18) US COURT DECISION PROVIDES CLARITY FOR LAUNCH OF RANBAXY'S CLARITHROMYCIN 500 MG EXTENDED RELEASE (ER) TABLETS UPON APPROVAL (Press Releases 12-Nov 10:15) Ranbaxy Labs gets favourable US court ruling on 2 patents (Corporate News 11-Nov 17:37) RANBAXY CONSOLIDATES RELATIONSHIP WITH JAPAN JV PARTNER NIPPON CHEMIPHAR (Press Releases 11-Nov 13:49) Ranbaxy gets applause for hiking stake in Japanese JV (Hot Pursuit 11-Nov 11:34) Ranbaxy to increase stake in Japanese joint venture (Corporate News 11-Nov 11:06) US COURT DECISION PROVIDES CLARITY FOR LAUNCH OFRANBAXY’S CLARITHROMYCIN 500 MG EXTENDED RELEASE (ER) TABLETS UPON APPROVAL (Press Releases 11-Nov 10:13) Ranbaxy wins case against Pfizer Inc on a process patent (Corporate News 10-Nov 11:36) RANBAXY WINS ON ATORVASTATIN PROCESS PATENT IN NORWAY – WILL APPEAL COURT RULINGON INTERMEDIATE COMPOUND PATENT (Press Releases 10-Nov 11:31) Ranbaxy gains as it wins patent case against Pfizer in Norway (Hot Pursuit 10-Nov 10:43) Ranbaxy bounces back (Hot Pursuit 08-Nov 11:58) Ranbaxy Laboratories’ shareholders approve sale of allied businesses (Corporate News 05-Nov 10:44) Ranbaxy granted permission to appeal on patent relating to Atorvastatin (Corporate News 05-Nov 10:27) RANBAXY GRANTED PERMISSION TO APPEAL U.K. HIGH COURT JUDGEMENT ON PATENT RELATING TO ATORVASTATIN (Press Releases 03-Nov 09:40) Ranbaxy Clarifies 180 Day Exclusivities relating to Pravastatin 80mg and Simvastatin  80mg Tablets (Press Releases 31-Oct 10:28) Ranbaxy donates for earthquake victims (Corporate News 27-Oct 17:26) Ranbaxy Laboratories (Analyst Meet / AGM - Conference Call 25-Oct 11:07) Q3 results prove bitter pill for Ranbaxy (Hot Pursuit 24-Oct 16:35) Ranbaxy Laboratories (Results - Analysis 22-Oct 18:50) Ranbaxy Laboratories to hike authorised share capital (Corporate News 21-Oct 15:47) Ranbaxy Laboratories to raise funds through issue of securities (Corporate News 21-Oct 15:43) Ranbaxy Laboratories Q3 posts loss of Rs 10.77 cr (Results - Announcements 21-Oct 15:38) RANBAXY Q3 GLOBAL SALES AT USD 298 MN, UP BY 2% Board Approves Interim Dividend of 50 % (Rs 2.50 per share) (Press Releases 21-Oct 11:19) Ranbaxy recovers (Hot Pursuit 20-Oct 11:48) Ranbaxy Laboratories’ antimalarial molecule completes POC Phase II studies (Corporate News 19-Oct 17:21) RANBAXY ' S ANTIMALARIAL MOLECULE SUCCESSFULLY COMPLETES POC PHASE II STUDIES (Press Releases 19-Oct 11:17) RANBAXY’S ANTIMALARIAL MOLECULE SUCCESSFULLY COMPLETES POC PHASE II STUDIES (Press Releases 19-Oct 10:10) Ranbaxy Laboratories loses further ground (Hot Pursuit 14-Oct 12:59) Ranbaxy files suit against Barr Laboratories, Teva Pharma (Corporate News 13-Oct 10:48) Adverse UK court ruling on Lipitor hits Ranbaxy hard (Hot Pursuit 13-Oct 10:06) Ranbaxy Laboratories gets USFDA nod to market Gabapentin Capsules (Corporate News 10-Oct 13:46) Ranbaxy Laboratories gets US FDA’s final approval for Glimepiride Tablets (Corporate News 07-Oct 13:20) Ranbaxy Laboratories figures in the thick of the action (Hot Pursuit 07-Oct 10:49) ANOTHER RANBAXY ARV PRE-QUALIFIED BY WHO (Press Releases 30-Sep 20:37) RANBAXY GAINS APPROVAL TO MARKET PSEUDOEPHEDRINE HYDROCHLORIDE EXTENDED-RELEASE TABLETS (Press Releases 30-Sep 11:46) Ranbaxy Laboratories seeks shareholder nod for sale of allied business (Corporate News 28-Sep 13:13) Ranbaxy Laboratories in licensing agreement with Lupin (Corporate News 27-Sep 15:29) RANBAXY TO MARKET LUPIN'S TUBERCULOSIS BRANDS IN SEVERELY AFFECTED WEST & NORTH AFRICAN MARKETS (Press Releases 27-Sep 11:15) India’s largest pharmaceutical company to bring high quality, affordable drugs to Canada (Press Releases 22-Sep 22:11) Ranbaxy Labs bags US FDA approval for Zidovudine Tablets (Corporate News 20-Sep 17:14) RANBAXY RECEIVES APPROVAL FROM USFDA TO MARKET ZIDOVUDINE TABLETS (Press Releases 20-Sep 14:30) RANBAXY RECEIVES TENTATIVE APPROVAL FROM USFDA TO MARKET TOLTERODINE TARTRATE TABLETS (Press Releases 19-Sep 14:40) Ranbaxy Labs gets tentative US FDA nod for Tolterodine Tartrate Tablets (Corporate News 19-Sep 13:33) RANBAXY RECEIVES FINAL APPROVAL FROM USFDA FOR GABAPENTIN TABLETS (Press Releases 16-Sep 20:02) Ranbaxy Laboratories gets much pursued on USFDA nod for generics drug (Hot Pursuit 16-Sep 12:05) Ranbaxy Labs gets US FDA nod for Gabapentin (Corporate News 16-Sep 12:00) RANBAXY LAUNCHES ITALIAN OPERATIONS (Press Releases 13-Sep 18:47) Ranbaxy launches Italian operations (Corporate News 13-Sep 14:01) Ranbaxy Laboratories plans raising of funds (Corporate News 09-Sep 16:49) Ranbaxy Laboratories moves for divestment in allied business portfolio (Corporate News 08-Sep 16:51) Ranbaxy gains on US listing proposal (Hot Pursuit 05-Sep 12:09) Ranbaxy mulls US listing (Corporate News 03-Sep 17:07) RANBAXY TO FOCUS ON PHARMACEUTICALS BUSINESS (Press Releases 02-Sep 13:14) Ranbaxy to divest allied businesses portfolio (Corporate News 02-Sep 12:06) RANBAXY RECEIVES PRESTIGIOUS SUPPLIER QUALITY AWARD FROM CARDINAL HEALTH (Press Releases 25-Aug 16:19) Ranbaxy receives supplier quality award from Cardinal Health (Corporate News 25-Aug 12:57) Ranbaxy opens third state of the art R&D facility on Gurgaon campus to focus on NCE Discovery Research (Press Releases 22-Aug 18:09) Ranbaxy Laboratories gains as it eyes acquisitions (Hot Pursuit 17-Aug 10:08) RANBAXY OPENS THIRD STATE OF THE ART R&D FACILITY ON GURGAON CAMPUS TO FOCUS ON NCE DISCOVERY RESEARCH (Press Releases 16-Aug 21:25) Ranbaxy opens R&D facility on Gurgaon campus (Corporate News 16-Aug 15:31) Ranbaxy bounces back (Hot Pursuit 12-Aug 13:52) RANBAXY’S SEVEN ARVs ON WHO’s PRE-QUALIFICATION LIST (Press Releases 11-Aug 21:26) Ranbaxy Laboratories denies acquisition move (Corporate News 04-Aug 13:53) RANBAXY RECEIVES TENTATIVE APPROVAL TO MARKET SUMATRIPTAN SUCCINATE TABLETS (Press Releases 03-Aug 18:12) Ranbaxy receives tentative approval to market Sumatriptan Succinate tablets (Corporate News 03-Aug 14:47) RANBAXY SETS UP ADDITIONAL MANUFACTURING FACILITY IN MALAYSIA (Press Releases 02-Aug 18:21) Ranbaxy sets up additional manufacturing facility in Malaysia (Corporate News 02-Aug 14:09) Ranbaxy Laboratories (Results - Analysis 29-Jul 22:46) Ranbaxy gains tentative approval to market additional strengths of glimepiride tablets (Corporate News 29-Jul 14:08) Ranbaxy Laboratories Q2 net profit at Rs 76.49 cr (Results - Announcements 29-Jul 12:08) Ranbaxy gains tentative approval to market additional strengths of glimepiride tablets (Corporate News 26-Jul 17:37) Ranbaxy Laboratories’ JV launches new tablet for diabetes (Corporate News 25-Jul 14:46) RANBAXY’S JOINT VENTURE WITH NIPPON CHEMIPHAR IN JAPAN (NIHON PHARMACEUTICAL INDUSTRY LIMITED) LAUNCHES – VOGSEAL FOR DIABETES, THE FIRST PRODUCT OF T (Press Releases 25-Jul 12:55) RANBAXY GAINS TENTATIVE APPROVAL TO MARKET GLIMEPIRIDE TABLETS (Press Releases 22-Jul 16:51) RANBAXY GAINS TENTATIVE APPROVAL TO MARKET GLIMEPIRIDE TABLETS (Press Releases 21-Jul 17:35) Ranbaxy Laboratories gains tentative approval to market Glimepiride tablets (Corporate News 21-Jul 13:31) RANBAXY RECEIVES USFDA APPROVAL FOR ZIDOVUDINE TABLETS (Press Releases 15-Jul 14:04) Ranbaxy Laboratories receives USFDA approval for Zidovudine Tablets (Corporate News 15-Jul 09:53) RANBAXY RECEIVES USFDA APPROVAL FOR ZIDOVUDINE TABLETS (Press Releases 14-Jul 20:32) RANBAXY GAINS APPROVAL TO MARKET METFORMIN XL TABLETS, 750 MG (Press Releases 04-Jul 20:25) RANBAXY RECEIVES TENTATIVE APPROVAL TO MARKET TERBINAFINE HYDROCHLORIDE 250 MG TABLETS (Press Releases 22-Jun 22:33) RANBAXY PHARMACEUTICALS INC, USA, RECEIVES PRESTIGIOUS OUTSTANDING SUPPLIER AWARD FROM WAL-MART (Press Releases 21-Jun 14:21) RANBAXY ACQUIRES GENERIC PRODUCT PORTFOLIO FROM EFARMES OF SPAIN (Press Releases 09-Jun 10:00) RANBAXY'S GOA (INDIA) MANUFACTURING PLANT RECEIVES MHRA, UK APPROVAL (Press Releases 02-Jun 12:20) RANBAXY RECEIVES INDIA’S FIRST APPROVAL FROM USFDA FOR AN ANTI RETROVIRAL DRUG UNDER THE U.S. PRESIDENT’S EMERGENCY PLAN FOR AIDS RELIEF INITIATIVE (Press Releases 31-May 13:56) RANBAXY ANNOUNCES THE LAUNCH OF CLARITHROMYCIN IR (Press Releases 25-May 14:38) Ranbaxy Laboratories (Analyst Meet / AGM - Conference Call 29-Apr 19:45) Ranbaxy Laboratories (Results - Analysis 29-Apr 14:53) RANBAXY Q1, 05 GLOBAL SALES AT USD 261 MN (Press Releases 28-Apr 16:01)